Induction and molecular signature of pathogenic TH17 cells

Abstract

Interleukin 17 (IL-17)-producing helper T cells (TH17 cells) are often present at the sites of tissue inflammation in autoimmune diseases, which has led to the conclusion that TH17 cells are main drivers of autoimmune tissue injury. However, not all TH17 cells are pathogenic; in fact, TH17 cells generated with transforming growth factor-β1 (TGF-β1) and IL-6 produce IL-17 but do not readily induce autoimmune disease without further exposure to IL-23. Here we found that the production of TGF-β3 by developing TH17 cells was dependent on IL-23, which together with IL-6 induced very pathogenic TH17 cells. Moreover, TGF-β3-induced TH17 cells were functionally and molecularly distinct from TGF-β1-induced TH17 cells and had a molecular signature that defined pathogenic effector TH17 cells in autoimmune disease.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: The induction of TGF-β3 in TH17 cells.
Figure 2: TGF-β3-induced TH17 cells are very pathogenic in inducing autoimmunity.
Figure 3: The pathogenicity of TH17 cells induced with TGF-β3 and IL-6 is very similar to that of TH17 cells induced with IL-1β, IL-6 and IL-23.
Figure 4: Identification of transcriptional signature for pathogenic TH17 cells.
Figure 5: Exogenous TGF-β3 can overcome the absence of T-bet.

Accession codes

Primary accessions

Gene Expression Omnibus

References

  1. 1

    Abbas, A.K., Murphy, K.M. & Sher, A. Functional diversity of helper T lymphocytes. Nature 383, 787–793 (1996).

  2. 2

    Szabo, S.J. et al. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100, 655–669 (2000).

  3. 3

    Szabo, S.J., Sullivan, B.M., Peng, S.L. & Glimcher, L.H. Molecular mechanisms regulating Th1 immune responses. Annu. Rev. Immunol. 21, 713–758 (2003).

  4. 4

    Zheng, W. & Flavell, R.A. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89, 587–596 (1997).

  5. 5

    Mosmann, T.R. & Coffman, R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7, 145–173 (1989).

  6. 6

    Kuchroo, V.K. et al. T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire. Annu. Rev. Immunol. 20, 101–123 (2002).

  7. 7

    Ferber, I.A. et al. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156, 5–7 (1996).

  8. 8

    Wildbaum, G., Youssef, S., Grabie, N. & Karin, N. Neutralizing antibodies to IFN-γ-inducing factor prevent experimental autoimmune encephalomyelitis. J. Immunol. 161, 6368–6374 (1998).

  9. 9

    Bettelli, E. et al. Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis. J. Exp. Med. 200, 79–87 (2004).

  10. 10

    Bettelli, E. et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235–238 (2006).

  11. 11

    Bettelli, E., Korn, T., Oukka, M. & Kuchroo, V.K. Induction and effector functions of TH17 cells. Nature 453, 1051–1057 (2008).

  12. 12

    Mangan, P.R. et al. Transforming growth factor-β induces development of the TH17 lineage. Nature 441, 231–234 (2006).

  13. 13

    Veldhoen, M., Hocking, R.J., Atkins, C.J., Locksley, R.M. & Stockinger, B. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24, 179–189 (2006).

  14. 14

    Korn, T., Bettelli, E., Oukka, M. & Kuchroo, V.K. IL-17 and Th17 cells. Annu. Rev. Immunol. 27, 485–517 (2009).

  15. 15

    Ivanov, I.I. et al. The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126, 1121–1133 (2006).

  16. 16

    Awasthi, A. et al. Cutting edge: IL-23 receptor gfp reporter mice reveal distinct populations of IL-17-producing cells. J. Immunol. 182, 5904–5908 (2009).

  17. 17

    Cua, D.J. et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421, 744–748 (2003).

  18. 18

    McGeachy, M.J. et al. The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17–producing effector T helper cells in vivo. Nat. Immunol. 10, 314–324 (2009).

  19. 19

    Duerr, R.H. et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314, 1461–1463 (2006).

  20. 20

    Rahman, P. et al. Association of interleukin-23 receptor variants with ankylosing spondylitis. Arthritis Rheum. 58, 1020–1025 (2008).

  21. 21

    McGeachy, M.J. et al. TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell-mediated pathology. Nat. Immunol. 8, 1390–1397 (2007).

  22. 22

    Jäger, A., Dardalhon, V., Sobel, R.A., Bettelli, E. & Kuchroo, V.K. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J. Immunol. 183, 7169–7177 (2009).

  23. 23

    Esplugues, E. et al. Control of TH17 cells occurs in the small intestine. Nature 475, 514–518 (2011).

  24. 24

    Yang, Y. et al. T-bet is essential for encephalitogenicity of both Th1 and Th17 cells. J. Exp. Med. 206, 1549–1564 (2009).

  25. 25

    Codarri, L. et al. RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 12, 560–567 (2011).

  26. 26

    El-Behi, M. et al. The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat. Immunol. 12, 568–575 (2011).

  27. 27

    McQualter, J.L. et al. Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis. J. Exp. Med. 194, 873–882 (2001).

  28. 28

    Yang, L.T., Li, W.Y. & Kaartinen, V. Tissue-specific expression of Cre recombinase from the Tgfb3 locus. Genesis 46, 112–118 (2008).

  29. 29

    Lyons, R.M., Miller, D.A., Graycar, J.L., Moses, H.L. & Derynck, R. Differential binding of transforming growth factor-β1, -β2, and -β3 by fibroblasts and epithelial cells measured by affinity cross-linking of cell surface receptors. Mol. Endocrinol. 5, 1887–1896 (1991).

  30. 30

    Graycar, J.L. et al. Human transforming growth factor-β3: recombinant expression, purification, and biological activities in comparison with transforming growth factors-β1 and -β2. Mol. Endocrinol. 3, 1977–1986 (1989).

  31. 31

    Veldhoen, M., Hocking, R.J., Flavell, R.A. & Stockinger, B. Signals mediated by transforming growth factor-β initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nat. Immunol. 7, 1151–1156 (2006).

  32. 32

    Ghoreschi, K. et al. Generation of pathogenic TH17 cells in the absence of TGF-β signalling. Nature 467, 967–971 (2010).

  33. 33

    Hirota, K. et al. Fate mapping of IL-17-producing T cells in inflammatory responses. Nat. Immunol. 12, 255–263 (2011).

  34. 34

    O'Connor, R.A. et al. Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis. J. Immunol. 181, 3750–3754 (2008).

  35. 35

    Gocke, A.R. et al. T-bet regulates the fate of Th1 and Th17 lymphocytes in autoimmunity. J. Immunol. 178, 1341–1348 (2007).

  36. 36

    Park, I.K., Shultz, L.D., Letterio, J.J. & Gorham, J.D. TGF-β1 inhibits T-bet induction by IFN-γ in murine CD4+ T cells through the protein tyrosine phosphatase Src homology region 2 domain-containing phosphatase-1. J. Immunol. 175, 5666–5674 (2005).

  37. 37

    Zhou, L. et al. IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8, 967–974 (2007).

  38. 38

    Walline, C.C., Kanakasabai, S. & Bright, J.J. IL-7Rα confers susceptibility to experimental autoimmune encephalomyelitis. Genes Immun. 12, 1–14 (2011).

  39. 39

    Liu, X. et al. Crucial role of interleukin-7 in T helper type 17 survival and expansion in autoimmune disease. Nat. Med. 16, 191–197 (2010).

  40. 40

    Lundmark, F. et al. Variation in interleukin 7 receptor α chain (IL7R) influences risk of multiple sclerosis. Nat. Genet. 39, 1108–1113 (2007).

  41. 41

    Gregory, S.G. et al. Interleukin 7 receptor α chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat. Genet. 39, 1083–1091 (2007).

  42. 42

    Veldhoen, M. et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 453, 106–109 (2008).

  43. 43

    Quintana, F.J. et al. Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor. Nature 453, 65–71 (2008).

  44. 44

    Bauquet, A.T. et al. The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells. Nat. Immunol. 10, 167–175 (2008).

  45. 45

    Apetoh, L. et al. The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat. Immunol. 11, 854–861 (2010).

  46. 46

    Zielinski, C.E. et al. Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β. Nature 484, 514–518 (2012).

  47. 47

    Awasthi, A. et al. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat. Immunol. 8, 1380–1389 (2007).

  48. 48

    Reich, M. et al. GenePattern 2.0. Nat. Genet. 38, 500–501 (2006).

  49. 49

    Irizarry, R.A. et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4, 249–264 (2003).

  50. 50

    Johnson, W.E., Li, C. & Rabinovic, A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8, 118–127 (2007).

Download references

Acknowledgements

We thank R. Bomireddy (University of Arizona) for mice with loxP-flanked Tgfb3 alleles; and D. Kozoriz for cell sorting. Supported by the US National Institutes of Health (NS030843, NS045937, AI073748 and AI045757 to V.K.K.; AI075285 and AI093903 to F.J.Q.; 1P01HG005062-01 and DP1-OD003958-01 to A.R.; and K01DK090105 to S.X.), the National Multiple Sclerosis Society (RG2571; RG4111A1 to F.J.Q.), the Crohn's and Colitis Foundation of America (A.A.), the Merkin Foundation for Stem Cell Research at the Broad Institute, the National Human Genome Research Institute and the Howard Hughes Medical Institute.

Author information

Y.L. and A.A. designed the study, did experiments, analyzed data and wrote the manuscript; A.P., S.X., S.K., M.K. and C.W. did in vitro experiments; N.Y., F.J.Q. and A.R. did the bioinformatics analysis of gene-expression data; R.A.S. did the immunohistochemical analysis; D.A.H. provided discussions; and V.K.K. and A.A. supervised the study and edited the manuscript.

Correspondence to Amit Awasthi or Vijay K Kuchroo.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–3 and Table 1 (PDF 1440 kb)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Lee, Y., Awasthi, A., Yosef, N. et al. Induction and molecular signature of pathogenic TH17 cells. Nat Immunol 13, 991–999 (2012). https://doi.org/10.1038/ni.2416

Download citation

Further reading